Analysis of the mortality of patients with systemic lupus erythematosus. i
Jacobelli, S.; Massardo, L.; Rodríguez, G.; Rosenberg, H.; Rivero, S.
Revista Medica de Chile 113(8): 744-750
1985
ISSN/ISBN: 0034-9887 PMID: 3832259 Document Number: 248793
Document emailed within 1 workday
Related Documents
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222Schur, P.H. 1990: Fingerprint analysis of patients with systemic lupus erythematosus and their relatives Journal of Rheumatology 17(4): 482-484
Huang, M.X. 1982: Clinical analysis of immunologic changes in patients with systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 21(6): 323-326
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Abu-Shakra, M.; Urowitz, M.B.; Gladman, D.D.; Gough, J. 1995: Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality Journal of Rheumatology 22(7): 1265-1270
Okubo, Y. 1991: Analysis of components of immune complexes in sera of patients with systemic lupus erythematosus Ryumachi 31(1): 36-44
Ginzler, E.; Berg, A. 1987: Mortality in systemic lupus erythematosus Journal of Rheumatology. Suppl 14(Suppl 13): 218-222
Watad, A.; Tiosano, S.; Azrielant, S.; Whitby, A.; Comaneshter, D.; Cohen, A.D.; Shoenfeld, Y.; Amital, H. 2017: Low levels of calcium or vitamin D - which is more important in systemic lupus erythematosus patients? An extensive data analysis Clinical and Experimental Rheumatology 35(1): 108-112
Huang, J.L.; Lin, C.J.; Hung, I.J.; Luo, S.F. 1994: The morbidity and mortality associated with childhood onset systemic lupus erythematosus Changgeng Yi Xue Za Zhi 17(2): 113-120
Wahl, D.G.; Bounameaux, H.; de Moerloose, P.; Sarasin, F.P. 2000: Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis Archives of Internal Medicine 160(13): 2042-2048
Leong, K.P.; Tee, N.W.; Yap, W.M.; Chee, T.S.; Koh, E.T. 2000: Nocardiosis in patients with systemic lupus erythematosus. the Singapore Lupus Study Group Journal of Rheumatology 27(5): 1306-1312
Bhandari, B.; Pal, A.; Maulik, S.; Chakraborti, S. 2012: Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years Journal of the Indian Medical Association 110(10): 710-714
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Tanaka, Y.; Saito, K.; Suzuki, H.; Eto, S.; Yamashita, U. 1989: Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression Journal of Immunology 143(5): 1584-1590
Tsuchiya, N.; Mitamura, T.; Goto, M.; Moroi, Y.; Kinoshita, M.; Yokohari, R.; Miyamoto, T. 1988: 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells Journal of Rheumatology 15(6): 946-951
Timeskov, I.S.; Chirkina, S.S.; Dolgobvorova, K.F.; Gil'fanov, R.N.; Zhuravleva, S.I. 1979: Evaluation of work capacity of patients with systemic lupus erythematosus and systemic scleroderma Terapevticheskii Arkhiv 51(1): 68-71
Mok, C.Chiu.; To, C.Hung.; Ho, L.Yin.; Yu, K.Lung. 2008: Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006 Journal of rheumatology 35(10): 1978-1982
Converso, M.; Bertero, M.T.; Vallario, A.; Caligaris-Cappio, F. 2000: Analysis of T-cell clones in systemic lupus erythematosus Haematologica 85(2): 118-123
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924